The trademark application LENTICURE was filed by LentiCure B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on October 21, 2024, and still open for oppositions.
The application was filed in Dutch (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations and substances for the treatment of metabolic, muscular, immune system and central nervous system related diseases and disorders
Gene therapy products, namely, genetically engineered tissues for transplant purposes
Stem cells for medical purposes.
The mark was filed in class 42 with following description of goods:
Gene therapy research
Stem cell research
Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Research and development services in the field of medical and pharmaceutical preparations
Medical research laboratory services in the field of gene therapy
Laboratory research services relating to pharmaceuticals
Scientific, pharmaceutical and medical research and development in the field of gene modification, gene editing, gene correction, gene repair, gene modulation, cell therapy, cellular modification and gene therapy
Medical development services, namely, custom manufacture of cells for diagnostic, medical and commercial applications in relation to cell and gene therapies.
The mark was filed in class 44 with following description of goods:
Stem cell therapy services
Gene therapy services
Stem cell storage
Medical analysis services for diagnostic and treatment purposes provided by medical laboratories
Medical services in the field of metabolic, muscular, immune system and central nervous system related diseases and disorders
Collection and preservation of human genetic resources for medical diagnosis and treatment.